SCHEDULE 13D/A//SEC Filing
BridgeBio Pharma, Inc. SCHEDULE 13D/A
Accession 0000905148-25-004059
CIK 0001103804other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:52 PM ET
Size
37.0 KB
Accession
0000905148-25-004059
Documents
Issuer
VIKING GLOBAL INVESTORS LP
CIK 0001103804
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001103804
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:52 PM ET
- Size
- 37.0 KB